Who Owns ASBP?
Aspire Biopharma Holdings, Inc. — Institutional Ownership & 13F Holdings
$0.27
+0.07 (+31.76%)
Market Cap
$4.3M
Shares Outstanding
3,461,153
Institutional Holders
15
Total Inst. Value
$693K
% of Float Held
—
QoQ Holder Change
—
Institutional data as of Q1 2025
Top 10 Institutional Holders(Q1 2025)
| # | Fund | Value | Shares |
|---|---|---|---|
| 1 | TORONTO DOMINION BANK | $350K | 516,845 |
| 2 | Harraden Circle Investments, LLC | $87K | 150,000 |
| 3 | Optivise Advisory Services LLC | $62K | 106,446 |
| 4 | Procyon Advisors, LLC | $57K | 98,500 |
| 5 | PERISCOPE CAPITAL INC. | $34K | 75,000 |
| 6 | Platform Technology Partners | $22K | 37,611 |
| 7 | UBS Group AG | $17K | 29,945 |
| 8 | TWO SIGMA SECURITIES, LLC | $16K | 27,413 |
| 9 | CITADEL ADVISORS LLC | $16K | 26,901 |
| 10 | JANE STREET GROUP, LLC | $12K | 21,019 |
Related Stocks
Frequently Asked Questions
How many institutional investors hold ASBP?
As of Q1 2025, 15 institutional investors report holding ASBP (Aspire Biopharma Holdings, Inc.) in their 13F filings.
Which hedge fund owns the most ASBP?
The largest institutional holder of ASBP is TORONTO DOMINION BANK with $350K in shares.
Are institutions buying or selling ASBP?
This quarter, 15 institutions opened new positions in ASBP and 0 closed their positions.
What is 13F institutional ownership?
SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.
How often is institutional ownership data updated?
13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.